Simon Hambidge
Concepts (335)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 46 | 2026 | 1423 | 3.380 |
Why?
| | Influenza Vaccines | 24 | 2026 | 529 | 2.930 |
Why?
| | Vaccines | 19 | 2025 | 389 | 2.610 |
Why?
| | Influenza, Human | 18 | 2026 | 616 | 2.120 |
Why?
| | Immunization | 8 | 2021 | 374 | 1.990 |
Why?
| | Immunization Programs | 10 | 2022 | 194 | 1.530 |
Why?
| | Pediatric Obesity | 10 | 2024 | 637 | 1.450 |
Why?
| | Adverse Drug Reaction Reporting Systems | 10 | 2023 | 81 | 1.230 |
Why?
| | Infant | 56 | 2026 | 10034 | 1.070 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 10 | 2017 | 91 | 1.030 |
Why?
| | Child Health Services | 5 | 2022 | 185 | 0.980 |
Why?
| | Measles-Mumps-Rubella Vaccine | 9 | 2021 | 47 | 0.960 |
Why?
| | Vaccination Coverage | 5 | 2026 | 103 | 0.950 |
Why?
| | Parents | 8 | 2021 | 1403 | 0.920 |
Why?
| | Child, Preschool | 49 | 2026 | 11787 | 0.870 |
Why?
| | Chickenpox Vaccine | 9 | 2021 | 75 | 0.840 |
Why?
| | Attitude to Health | 3 | 2017 | 436 | 0.840 |
Why?
| | Reminder Systems | 3 | 2026 | 141 | 0.840 |
Why?
| | Terminology as Topic | 2 | 2017 | 255 | 0.820 |
Why?
| | Cohort Studies | 38 | 2024 | 5960 | 0.740 |
Why?
| | Managed Care Programs | 5 | 2017 | 138 | 0.730 |
Why?
| | Female | 99 | 2026 | 78271 | 0.700 |
Why?
| | Counseling | 3 | 2017 | 408 | 0.690 |
Why?
| | Government Programs | 1 | 2021 | 26 | 0.680 |
Why?
| | Immunization Schedule | 5 | 2021 | 187 | 0.670 |
Why?
| | United States | 48 | 2026 | 15966 | 0.660 |
Why?
| | Colorado | 20 | 2026 | 4564 | 0.660 |
Why?
| | Humans | 125 | 2026 | 144759 | 0.630 |
Why?
| | Information Storage and Retrieval | 3 | 2020 | 121 | 0.620 |
Why?
| | Vaccines, Combined | 5 | 2020 | 49 | 0.620 |
Why?
| | Adolescent | 49 | 2026 | 22428 | 0.620 |
Why?
| | Child | 51 | 2025 | 22633 | 0.620 |
Why?
| | Pregnancy | 30 | 2026 | 7190 | 0.620 |
Why?
| | Abortion, Spontaneous | 4 | 2025 | 115 | 0.610 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2025 | 1414 | 0.610 |
Why?
| | Whooping Cough | 5 | 2014 | 55 | 0.600 |
Why?
| | Language | 4 | 2017 | 321 | 0.560 |
Why?
| | Male | 74 | 2026 | 72315 | 0.560 |
Why?
| | Preventive Health Services | 2 | 2013 | 152 | 0.560 |
Why?
| | Pregnancy Complications, Infectious | 8 | 2025 | 428 | 0.550 |
Why?
| | Population Surveillance | 9 | 2017 | 485 | 0.550 |
Why?
| | Pneumococcal Vaccines | 3 | 2022 | 130 | 0.550 |
Why?
| | Seizures, Febrile | 5 | 2017 | 22 | 0.540 |
Why?
| | Anemia, Sickle Cell | 2 | 2011 | 312 | 0.520 |
Why?
| | Urban Population | 5 | 2016 | 491 | 0.510 |
Why?
| | Wounds and Injuries | 4 | 2008 | 956 | 0.510 |
Why?
| | School Health Services | 4 | 2014 | 224 | 0.500 |
Why?
| | Vulnerable Populations | 2 | 2009 | 177 | 0.490 |
Why?
| | Safety-net Providers | 4 | 2021 | 125 | 0.470 |
Why?
| | Young Adult | 31 | 2026 | 14105 | 0.460 |
Why?
| | Dental Caries | 1 | 2017 | 173 | 0.460 |
Why?
| | Oral Health | 1 | 2017 | 139 | 0.450 |
Why?
| | Seizures | 3 | 2014 | 460 | 0.450 |
Why?
| | Chickenpox | 2 | 2020 | 81 | 0.440 |
Why?
| | Adult | 44 | 2026 | 40449 | 0.440 |
Why?
| | Incidence | 18 | 2024 | 2879 | 0.430 |
Why?
| | Retrospective Studies | 37 | 2026 | 17066 | 0.430 |
Why?
| | Body Mass Index | 6 | 2024 | 2438 | 0.430 |
Why?
| | Office Visits | 2 | 2007 | 90 | 0.420 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2014 | 9 | 0.420 |
Why?
| | Emergency Service, Hospital | 6 | 2014 | 2310 | 0.420 |
Why?
| | Infant, Newborn | 20 | 2026 | 6429 | 0.410 |
Why?
| | Case-Control Studies | 14 | 2025 | 3604 | 0.390 |
Why?
| | Product Surveillance, Postmarketing | 6 | 2022 | 72 | 0.390 |
Why?
| | Primary Health Care | 6 | 2021 | 1733 | 0.390 |
Why?
| | Self Report | 4 | 2026 | 872 | 0.390 |
Why?
| | Hospitalization | 6 | 2020 | 2433 | 0.390 |
Why?
| | Pertussis Vaccine | 2 | 2011 | 24 | 0.390 |
Why?
| | Bronchiolitis | 1 | 2014 | 87 | 0.380 |
Why?
| | Electronic Health Records | 7 | 2026 | 1173 | 0.380 |
Why?
| | Genes, MHC Class II | 1 | 2012 | 76 | 0.380 |
Why?
| | Papillomavirus Vaccines | 1 | 2016 | 297 | 0.370 |
Why?
| | Delivery of Health Care | 2 | 2017 | 947 | 0.360 |
Why?
| | Weight Reduction Programs | 2 | 2024 | 136 | 0.360 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2014 | 182 | 0.360 |
Why?
| | Treatment Refusal | 2 | 2010 | 98 | 0.360 |
Why?
| | Health Promotion | 2 | 2023 | 774 | 0.350 |
Why?
| | Rotavirus Vaccines | 3 | 2022 | 37 | 0.350 |
Why?
| | Health Services Research | 2 | 2012 | 396 | 0.350 |
Why?
| | Vaccines, Inactivated | 4 | 2012 | 70 | 0.320 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2010 | 47 | 0.320 |
Why?
| | Health Personnel | 1 | 2017 | 748 | 0.320 |
Why?
| | Meningococcal Vaccines | 3 | 2017 | 58 | 0.320 |
Why?
| | Communication Barriers | 1 | 2011 | 124 | 0.310 |
Why?
| | Immunization, Secondary | 3 | 2025 | 91 | 0.310 |
Why?
| | Risk Assessment | 12 | 2020 | 3671 | 0.300 |
Why?
| | Case Management | 1 | 2009 | 67 | 0.290 |
Why?
| | Urban Health | 2 | 2006 | 96 | 0.290 |
Why?
| | Middle Aged | 26 | 2026 | 35875 | 0.290 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 2 | 2022 | 91 | 0.280 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 1 | 2008 | 17 | 0.270 |
Why?
| | Congenital Abnormalities | 3 | 2017 | 104 | 0.270 |
Why?
| | Cross-Sectional Studies | 8 | 2026 | 5868 | 0.270 |
Why?
| | Anaphylaxis | 3 | 2021 | 102 | 0.270 |
Why?
| | Health Services Accessibility | 4 | 2011 | 1098 | 0.270 |
Why?
| | Insurance, Health | 3 | 2012 | 302 | 0.260 |
Why?
| | Pediatrics | 2 | 2006 | 1114 | 0.260 |
Why?
| | Poverty | 5 | 2021 | 529 | 0.250 |
Why?
| | Measles | 2 | 2020 | 46 | 0.250 |
Why?
| | Child Care | 1 | 2007 | 36 | 0.250 |
Why?
| | Accident Prevention | 1 | 2006 | 26 | 0.250 |
Why?
| | Community Health Services | 2 | 2010 | 233 | 0.250 |
Why?
| | Child Development | 1 | 2011 | 484 | 0.240 |
Why?
| | Internet | 1 | 2011 | 699 | 0.240 |
Why?
| | Risk | 9 | 2017 | 911 | 0.240 |
Why?
| | Herpes Zoster | 2 | 2020 | 315 | 0.240 |
Why?
| | Stillbirth | 2 | 2024 | 77 | 0.230 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 2 | 2017 | 28 | 0.230 |
Why?
| | Chorioamnionitis | 2 | 2017 | 45 | 0.230 |
Why?
| | International Classification of Diseases | 2 | 2020 | 147 | 0.220 |
Why?
| | Aluminum | 2 | 2022 | 43 | 0.220 |
Why?
| | Developmental Disabilities | 2 | 2020 | 281 | 0.220 |
Why?
| | Narration | 1 | 2026 | 75 | 0.220 |
Why?
| | Respiratory Syncytial Virus Vaccines | 1 | 2025 | 39 | 0.220 |
Why?
| | Prenatal Care | 2 | 2017 | 307 | 0.210 |
Why?
| | Athletic Injuries | 3 | 2006 | 569 | 0.210 |
Why?
| | Mass Screening | 2 | 2015 | 1347 | 0.200 |
Why?
| | Patient Acceptance of Health Care | 5 | 2024 | 885 | 0.200 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2025 | 136 | 0.200 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2014 | 96 | 0.200 |
Why?
| | Seasons | 6 | 2024 | 556 | 0.190 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 3 | 2022 | 257 | 0.190 |
Why?
| | Smallpox Vaccine | 1 | 2022 | 23 | 0.190 |
Why?
| | Multivariate Analysis | 4 | 2015 | 1539 | 0.190 |
Why?
| | Cataplexy | 1 | 2022 | 8 | 0.180 |
Why?
| | Bell Palsy | 1 | 2022 | 9 | 0.180 |
Why?
| | Narcolepsy | 1 | 2022 | 25 | 0.180 |
Why?
| | Delivery of Health Care, Integrated | 3 | 2021 | 299 | 0.180 |
Why?
| | Eczema | 1 | 2022 | 66 | 0.180 |
Why?
| | Thrombocytopenia | 2 | 2022 | 205 | 0.180 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 103 | 0.180 |
Why?
| | Healthcare Disparities | 2 | 2021 | 727 | 0.170 |
Why?
| | Pregnancy Outcome | 5 | 2025 | 476 | 0.170 |
Why?
| | Motivation | 2 | 2017 | 610 | 0.170 |
Why?
| | Disease Outbreaks | 1 | 2024 | 422 | 0.170 |
Why?
| | Premature Birth | 4 | 2024 | 380 | 0.170 |
Why?
| | Fever | 2 | 2013 | 311 | 0.170 |
Why?
| | Risk Factors | 8 | 2020 | 10779 | 0.160 |
Why?
| | Pregnancy Complications | 3 | 2017 | 592 | 0.160 |
Why?
| | Databases, Factual | 4 | 2025 | 1486 | 0.160 |
Why?
| | Vaccination Refusal | 1 | 2021 | 64 | 0.160 |
Why?
| | Focus Groups | 2 | 2014 | 573 | 0.160 |
Why?
| | Mumps | 1 | 2020 | 22 | 0.160 |
Why?
| | Diphtheria-Tetanus Vaccine | 2 | 2009 | 5 | 0.150 |
Why?
| | Australia | 1 | 2020 | 286 | 0.150 |
Why?
| | Age Distribution | 4 | 2010 | 403 | 0.150 |
Why?
| | Sex Distribution | 4 | 2010 | 386 | 0.150 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 985 | 0.140 |
Why?
| | Tetanus Toxoid | 2 | 2015 | 34 | 0.140 |
Why?
| | Regression Analysis | 4 | 2015 | 1003 | 0.140 |
Why?
| | Community Health Centers | 2 | 2009 | 59 | 0.130 |
Why?
| | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2017 | 13 | 0.130 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2017 | 27 | 0.130 |
Why?
| | Diagnosis, Oral | 1 | 2017 | 8 | 0.130 |
Why?
| | Syncope | 1 | 2017 | 55 | 0.130 |
Why?
| | Paint | 1 | 2017 | 9 | 0.130 |
Why?
| | Practice Patterns, Physicians' | 1 | 2006 | 1356 | 0.130 |
Why?
| | Dentists | 1 | 2017 | 21 | 0.130 |
Why?
| | Confidence Intervals | 3 | 2021 | 333 | 0.130 |
Why?
| | Aged | 8 | 2025 | 25913 | 0.130 |
Why?
| | Infant, Small for Gestational Age | 2 | 2015 | 109 | 0.130 |
Why?
| | Fluorides | 1 | 2017 | 49 | 0.130 |
Why?
| | Preconception Care | 1 | 2017 | 50 | 0.130 |
Why?
| | Prevalence | 4 | 2020 | 2834 | 0.120 |
Why?
| | Caregivers | 1 | 2026 | 1049 | 0.120 |
Why?
| | Age Factors | 5 | 2017 | 3333 | 0.120 |
Why?
| | Logistic Models | 3 | 2015 | 2117 | 0.120 |
Why?
| | Drug Hypersensitivity | 1 | 2017 | 90 | 0.120 |
Why?
| | Phosphates | 1 | 2017 | 180 | 0.120 |
Why?
| | Educational Status | 2 | 2023 | 467 | 0.120 |
Why?
| | Infant, Newborn, Diseases | 1 | 2017 | 113 | 0.120 |
Why?
| | Registries | 4 | 2010 | 2385 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
| | Time Factors | 9 | 2022 | 7173 | 0.110 |
Why?
| | Causality | 2 | 2006 | 126 | 0.110 |
Why?
| | Sex Factors | 2 | 2021 | 2112 | 0.110 |
Why?
| | Health Care Surveys | 2 | 2007 | 539 | 0.110 |
Why?
| | Telemedicine | 1 | 2024 | 945 | 0.110 |
Why?
| | Parental Consent | 1 | 2014 | 25 | 0.100 |
Why?
| | Poliovirus Vaccine, Inactivated | 1 | 2014 | 27 | 0.100 |
Why?
| | Fruit | 1 | 2015 | 152 | 0.100 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2014 | 67 | 0.100 |
Why?
| | Vegetables | 1 | 2015 | 170 | 0.100 |
Why?
| | Computer Simulation | 3 | 2013 | 1025 | 0.100 |
Why?
| | Pandemics | 4 | 2024 | 1694 | 0.100 |
Why?
| | Bacterial Vaccines | 1 | 2014 | 63 | 0.100 |
Why?
| | Reimbursement Mechanisms | 1 | 2014 | 80 | 0.100 |
Why?
| | Predictive Value of Tests | 3 | 2009 | 2115 | 0.100 |
Why?
| | Patient Navigation | 1 | 2015 | 104 | 0.100 |
Why?
| | Social Environment | 1 | 2015 | 254 | 0.100 |
Why?
| | Papillomavirus Infections | 1 | 2017 | 345 | 0.100 |
Why?
| | Drug Eruptions | 1 | 2013 | 28 | 0.100 |
Why?
| | Rotavirus Infections | 2 | 2012 | 35 | 0.090 |
Why?
| | Infant, Premature, Diseases | 1 | 2014 | 111 | 0.090 |
Why?
| | Comprehension | 1 | 2014 | 180 | 0.090 |
Why?
| | Viral Vaccines | 1 | 2014 | 107 | 0.090 |
Why?
| | Health Policy | 1 | 2016 | 400 | 0.090 |
Why?
| | Utilization Review | 2 | 2009 | 39 | 0.090 |
Why?
| | Maternal Age | 2 | 2023 | 126 | 0.090 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5408 | 0.090 |
Why?
| | Intussusception | 1 | 2012 | 25 | 0.090 |
Why?
| | Health Services | 1 | 2013 | 115 | 0.090 |
Why?
| | Respiratory Tract Infections | 2 | 2026 | 397 | 0.090 |
Why?
| | Models, Theoretical | 2 | 2013 | 582 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2006 | 1326 | 0.090 |
Why?
| | Health Education | 1 | 2015 | 358 | 0.090 |
Why?
| | Electronic Mail | 1 | 2011 | 61 | 0.090 |
Why?
| | Parenting | 1 | 2015 | 318 | 0.080 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 13 | 0.080 |
Why?
| | Gastrointestinal Diseases | 1 | 2013 | 216 | 0.080 |
Why?
| | Database Management Systems | 1 | 2011 | 50 | 0.080 |
Why?
| | Asthma | 1 | 2022 | 1767 | 0.080 |
Why?
| | Health Care Costs | 1 | 2014 | 427 | 0.080 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 675 | 0.080 |
Why?
| | Longitudinal Studies | 2 | 2014 | 2947 | 0.080 |
Why?
| | Hepatitis A Vaccines | 1 | 2009 | 20 | 0.080 |
Why?
| | Altitude | 1 | 2014 | 473 | 0.080 |
Why?
| | Diphtheria Toxoid | 1 | 2009 | 13 | 0.080 |
Why?
| | Qualitative Research | 1 | 2017 | 1671 | 0.080 |
Why?
| | Hepatitis B Vaccines | 1 | 2009 | 43 | 0.070 |
Why?
| | Surveys and Questionnaires | 4 | 2025 | 6048 | 0.070 |
Why?
| | Acetaminophen | 1 | 2011 | 264 | 0.070 |
Why?
| | Drug Evaluation | 1 | 2008 | 79 | 0.070 |
Why?
| | Models, Statistical | 1 | 2013 | 681 | 0.070 |
Why?
| | Purpura, Thrombocytopenic | 1 | 2008 | 5 | 0.070 |
Why?
| | Medicaid | 2 | 2009 | 461 | 0.070 |
Why?
| | Gastroenteritis | 1 | 2009 | 63 | 0.070 |
Why?
| | Patient Readmission | 1 | 2014 | 758 | 0.070 |
Why?
| | Platelet Count | 1 | 2008 | 96 | 0.070 |
Why?
| | Splenectomy | 1 | 2008 | 65 | 0.070 |
Why?
| | Hypersensitivity | 1 | 2011 | 252 | 0.070 |
Why?
| | Acute Disease | 2 | 2008 | 1030 | 0.070 |
Why?
| | Communicable Disease Control | 1 | 2008 | 86 | 0.070 |
Why?
| | Probability | 1 | 2008 | 310 | 0.070 |
Why?
| | Ambulatory Care Facilities | 2 | 2009 | 265 | 0.070 |
Why?
| | Vaccines, Conjugate | 2 | 2022 | 60 | 0.070 |
Why?
| | House Calls | 1 | 2009 | 154 | 0.070 |
Why?
| | Health Surveys | 1 | 2009 | 518 | 0.060 |
Why?
| | Social Class | 1 | 2008 | 268 | 0.060 |
Why?
| | Domestic Violence | 1 | 2006 | 51 | 0.060 |
Why?
| | Multicenter Studies as Topic | 1 | 2008 | 405 | 0.060 |
Why?
| | Chronic Disease | 2 | 2013 | 1813 | 0.060 |
Why?
| | Cluster Analysis | 2 | 2006 | 521 | 0.060 |
Why?
| | Severity of Illness Index | 3 | 2010 | 2925 | 0.060 |
Why?
| | Pregnancy Trimester, Third | 1 | 2026 | 115 | 0.060 |
Why?
| | Skin | 1 | 2011 | 755 | 0.060 |
Why?
| | Patient Dropouts | 1 | 2006 | 65 | 0.060 |
Why?
| | Linear Models | 1 | 2008 | 854 | 0.060 |
Why?
| | Brain Ischemia | 1 | 2009 | 358 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2008 | 1306 | 0.060 |
Why?
| | Medication Adherence | 1 | 2009 | 539 | 0.060 |
Why?
| | Disease Progression | 2 | 2014 | 2847 | 0.050 |
Why?
| | Pregnancy Trimester, First | 2 | 2017 | 136 | 0.050 |
Why?
| | Research Design | 2 | 2013 | 1135 | 0.050 |
Why?
| | Accidents, Home | 1 | 2004 | 33 | 0.050 |
Why?
| | Survival Analysis | 1 | 2008 | 1382 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2021 | 3890 | 0.050 |
Why?
| | Vaccines, Attenuated | 2 | 2017 | 129 | 0.050 |
Why?
| | Attitude of Health Personnel | 1 | 2012 | 1185 | 0.050 |
Why?
| | Hospitals, General | 1 | 2024 | 26 | 0.050 |
Why?
| | Prospective Studies | 4 | 2021 | 7990 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2363 | 0.050 |
Why?
| | Physicians, Family | 1 | 2005 | 173 | 0.050 |
Why?
| | Physicians | 1 | 2012 | 939 | 0.050 |
Why?
| | Ambulatory Care | 2 | 2013 | 600 | 0.050 |
Why?
| | Public Health Informatics | 1 | 2003 | 10 | 0.050 |
Why?
| | Physician's Role | 1 | 2005 | 218 | 0.050 |
Why?
| | Accidents, Traffic | 1 | 2004 | 190 | 0.050 |
Why?
| | Family Practice | 1 | 2007 | 404 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2015 | 8265 | 0.050 |
Why?
| | Health Status | 1 | 2008 | 836 | 0.050 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1325 | 0.050 |
Why?
| | Benchmarking | 1 | 2024 | 188 | 0.050 |
Why?
| | Thigh | 2 | 2013 | 47 | 0.040 |
Why?
| | Odds Ratio | 2 | 2015 | 1075 | 0.040 |
Why?
| | Injections, Intramuscular | 2 | 2013 | 141 | 0.040 |
Why?
| | Public Health Surveillance | 1 | 2021 | 83 | 0.040 |
Why?
| | Arm | 2 | 2013 | 109 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2021 | 138 | 0.040 |
Why?
| | Algorithms | 2 | 2020 | 1837 | 0.040 |
Why?
| | Myocarditis | 1 | 2021 | 102 | 0.040 |
Why?
| | Systole | 1 | 2020 | 178 | 0.040 |
Why?
| | Pilot Projects | 1 | 2026 | 1886 | 0.040 |
Why?
| | Antigens | 1 | 2021 | 347 | 0.040 |
Why?
| | Poisson Distribution | 2 | 2011 | 78 | 0.040 |
Why?
| | Health Facilities | 1 | 2020 | 85 | 0.040 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 372 | 0.040 |
Why?
| | Stroke | 1 | 2009 | 1256 | 0.040 |
Why?
| | Mass Vaccination | 1 | 2019 | 18 | 0.040 |
Why?
| | Bias | 2 | 2013 | 202 | 0.040 |
Why?
| | Prognosis | 1 | 2008 | 4282 | 0.040 |
Why?
| | Practice Guidelines as Topic | 1 | 2006 | 1560 | 0.040 |
Why?
| | Birth Weight | 1 | 2021 | 522 | 0.030 |
Why?
| | Health Behavior | 2 | 2015 | 785 | 0.030 |
Why?
| | Gestational Age | 1 | 2021 | 975 | 0.030 |
Why?
| | Exercise | 2 | 2020 | 2201 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2020 | 672 | 0.030 |
Why?
| | Propensity Score | 1 | 2017 | 367 | 0.030 |
Why?
| | Biomarkers, Pharmacological | 1 | 2015 | 26 | 0.030 |
Why?
| | Computers | 1 | 2015 | 67 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2023 | 2832 | 0.030 |
Why?
| | Video Games | 1 | 2015 | 30 | 0.030 |
Why?
| | Demography | 1 | 2015 | 288 | 0.030 |
Why?
| | Television | 1 | 2015 | 72 | 0.030 |
Why?
| | Refugees | 1 | 2015 | 81 | 0.030 |
Why?
| | Vasculitis | 1 | 2014 | 69 | 0.030 |
Why?
| | Contraindications | 1 | 2014 | 91 | 0.030 |
Why?
| | Blood Pressure | 1 | 2020 | 1769 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2020 | 851 | 0.030 |
Why?
| | Family Characteristics | 1 | 2015 | 197 | 0.020 |
Why?
| | California | 1 | 2014 | 475 | 0.020 |
Why?
| | Emigrants and Immigrants | 1 | 2015 | 157 | 0.020 |
Why?
| | Drug Utilization | 1 | 2013 | 166 | 0.020 |
Why?
| | Parent-Child Relations | 1 | 2015 | 270 | 0.020 |
Why?
| | Monitoring, Immunologic | 1 | 2011 | 23 | 0.020 |
Why?
| | Placebos | 1 | 2011 | 192 | 0.020 |
Why?
| | Sample Size | 1 | 2011 | 123 | 0.020 |
Why?
| | Schools | 1 | 2014 | 453 | 0.020 |
Why?
| | Family | 1 | 2015 | 679 | 0.020 |
Why?
| | Overweight | 1 | 2015 | 609 | 0.020 |
Why?
| | Data Collection | 1 | 2013 | 633 | 0.020 |
Why?
| | Safety Management | 1 | 2011 | 121 | 0.020 |
Why?
| | Safety | 1 | 2011 | 356 | 0.020 |
Why?
| | Epidemiologic Methods | 1 | 2008 | 89 | 0.020 |
Why?
| | Curriculum | 1 | 2015 | 1059 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 779 | 0.020 |
Why?
| | Diet | 1 | 2015 | 1273 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2027 | 0.010 |
Why?
| | Health Care Reform | 1 | 2005 | 109 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1985 | 0.010 |
Why?
| | Health Services Needs and Demand | 1 | 2005 | 280 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2006 | 1720 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2006 | 3409 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2009 | 11679 | 0.010 |
Why?
|
|
Hambidge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|